undamentalytics Newsletter
Sign in

Ingevity Corp income statement

In fiscal 2025, Ingevity Corp reported revenue of $1.17bn, down 2.7% on the year before, operating income of $419m (a 35.9% margin) and net income of −$167m, or −$4.61 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1,0369589089721,1341,2931,2161,3921,6681,2161,2001,1681,160
Cost of revenue——6346437178117518791,098771735706683
Gross profit319275274329417482466513570445465462477
Research and development8171820222023263025252827
Selling, general and administrative1089396106132163149179199162158171165
Operating income213166164243321397398422453423426419—
Interest expense162019183355475262939878—
Income before tax20213787175222228235163270130−141−14238
Income tax70524330404454455824−19813
Net income1298035127169184181118212−5−430−16754
Diluted EPS$3.06$1.89$0.83$2.97$3.97$4.35$4.37$2.95$5.50−$0.15−$11.85−$4.61$1.51
Diluted shares (average)42m42m42m43m43m42m42m40m38m37m36m36m36m
EBITDA246201202283378482498532561546534525—

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: HWKN vs NGVTBCPC vs NGVTALTO vs NGVT

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Ingevity Corp's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ingevity Corp.